Viridian Therapeutics, Inc. (VRDN)
29.25
+0.08
(+0.27%)
USD |
NASDAQ |
Feb 06, 16:00
29.23
-0.02
(-0.07%)
After-Hours: 20:00
Viridian Therapeutics SG&A Expense (TTM) : 77.23M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 4.365M |
| ADMA Biologics, Inc. | 96.37M |
| Avantor, Inc. | 1.574B |
| Immunovant, Inc. | 79.15M |
| Plus Therapeutics, Inc. | 11.09M |